27.03.2024 11:56 | AZN, INDV, C4XD | C4X Discovery seeks AIM delisting but half-year revenue skyrockets | Alliance |
27.03.2024 07:00 | C4XD | Proposed Voluntary Delisting | RNS |
27.03.2024 07:00 | C4XD | Interim results | RNS |
23.01.2024 13:57 | C4XD | Result of AGM | RNS |
18.01.2024 07:00 | C4XD | Board Update | RNS |
16.01.2024 15:27 | MAB, MARS, C4XD | UK shareholder meetings calendar - next 7 days | Alliance |
04.01.2024 14:45 | C4XD | Holding(s) in Company | RNS |
03.01.2024 10:12 | AZN, MKA, GTC | AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals | Alliance |
03.01.2024 08:04 | AZN, C4XD | C4X receives USD11 million from AstraZeneca following NRF2 trials | Alliance |
03.01.2024 07:00 | C4XD | AstraZeneca $11m milestone payment to C4XD | RNS |
18.12.2023 15:31 | C4XD | Posting of 2023 Annual Report and Notice of AGM | RNS |
14.12.2023 11:25 | C4XD | C4X Discovery shares topple 10% as loss widens on higher costs | Alliance |
14.12.2023 07:00 | C4XD | Full Year Results | RNS |
07.12.2023 14:32 | STEM, SRP, IHP | UK earnings, trading statements calendar - next 7 days | Alliance |
07.12.2023 07:00 | C4XD | Notice of Results | RNS |
05.10.2023 14:35 | C4XD | Holding(s) in Company | RNS |
02.10.2023 12:36 | C4XD | Block listing Interim Review | RNS |
29.09.2023 11:14 | C4XD | Grant of Options and Directors Dealing | RNS |
28.09.2023 15:52 | C4XD | Holding(s) in Company | RNS |
01.09.2023 07:00 | C4XD | Total Voting Rights | RNS |
18.08.2023 12:45 | C4XD | Exercise of Options, Issue of Equity and TVR | RNS |
01.08.2023 17:39 | SLE, EXR, DBOX | TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands | Alliance |
01.08.2023 07:00 | C4XD | Divestment of Orexin-1 to Indivior for £15.95m | RNS |
20.06.2023 10:52 | C4XD | C4X Discovery chair steps down; Clive Dix named interim chair & CEO | Alliance |
20.06.2023 07:00 | C4XD | C4X Discovery Holdings plc: Board Change | RNS |
01.06.2023 17:32 | C4XD | C4X says MALT-1 study shows no UGT1A1 liability seen in competitors | Alliance |
01.06.2023 07:00 | C4XD | MALT-1 Inhibitor Programme Update | RNS |
26.04.2023 17:58 | C4XD, AEWU, CAT | EARNINGS SUMMARY: Bluebird swings to loss, RBG profit rises strongly | Alliance |
26.04.2023 07:00 | C4XD | Half Year Results | RNS |
19.04.2023 15:42 | W7L, TRI, STAN | UK earnings, trading statements calendar - next 7 days | Alliance |
19.04.2023 07:00 | C4XD | Notice of Results | RNS |
08.03.2023 14:49 | C4XD | Block Listing Interim Review | RNS |
22.02.2023 13:41 | C4XD | C4X Discovery launches medicine platform on Parkinson's study results | Alliance |
22.02.2023 07:00 | C4XD | C4XD and Garvan Institute collaboration | RNS |
24.01.2023 11:47 | C4XD | Result of AGM | RNS |
19.01.2023 16:54 | FSF, C4XD, MODE | TRADING UPDATES: Mode Global considers sale; RPS takeover complete | Alliance |
19.01.2023 07:00 | C4XD | MALT-1 Inhibitor Programme Update | RNS |
17.01.2023 15:55 | SNWS, C4XD | UK shareholder meetings calendar - next 7 days | Alliance |
10.01.2023 15:10 | AZN, C4XD | C4X Discovery promotes Nick Ray to chief scientific officer | Alliance |
10.01.2023 07:00 | C4XD | Nick Ray Appointed as Chief Scientific Officer | RNS |
19.12.2022 16:52 | C4XD | Posting of 2022 Annual Report and Notice of AGM | RNS |
15.12.2022 12:13 | AZN, C4XD | C4X Holdings loss widens; outlook strong amid AstraZeneca partnership | Alliance |
15.12.2022 07:00 | C4XD | Full Year Results | RNS |
08.12.2022 15:46 | SRP, RWS, LIB | UK earnings, trading statements calendar - next 7 days | Alliance |
28.11.2022 14:30 | C4XD | EQS-News: C4X Discovery signs potential $402mln deal | EQS |
28.11.2022 10:46 | C4XD, WPHO, INHC | AIM WINNERS & LOSERS: C4X shares jump on agreement with AstraZeneca | Alliance |
28.11.2022 09:00 | C4XD | Notice of Final Results | RNS |
28.11.2022 08:49 | AZN, C4XD | C4X Discovery shares up as signs USD400 million deal with AstraZeneca | Alliance |
28.11.2022 07:00 | C4XD | C4XD Agreement with AstraZeneca | RNS |
01.11.2022 14:03 | C4XD | Exercise of Options, Issue of Equity and TVR | RNS |
20.10.2022 21:54 | IGR, ARS, XPS | TRADING UPDATES: XPS Pensions revenue up; IG Design performing ahead | Alliance |
20.10.2022 07:00 | C4XD | C4XD and HitGen to collaborate in inflammation | RNS |
04.10.2022 14:56 | C4XD | Holding(s) in Company | RNS |
22.09.2022 16:40 | C4XD | Second Price Monitoring Extn | RNS |
22.09.2022 16:35 | C4XD | Price Monitoring Extension | RNS |
31.08.2022 11:10 | C4XD | Holding(s) in Company | RNS |
17.08.2022 16:06 | C4XD | Holding(s) in Company | RNS |
17.08.2022 15:43 | C4XD | Holding(s) in Company | RNS |
16.08.2022 14:17 | C4XD | Holding(s) in Company | RNS |
11.08.2022 13:17 | C4XD | UPDATE: C4X Discovery raises GBP5.7 million in oversubscribed placing | Alliance |
11.08.2022 12:43 | C4XD | Result of Placing to Raise £5.7 million | RNS |
11.08.2022 11:17 | C4XD, MRK | AIM WINNERS & LOSERS: MJ Hudson falls short of fundraising target | Alliance |
11.08.2022 10:49 | C4XD | IN BRIEF: C4X plans GBP5.7 million placing to aid drug development | Alliance |
11.08.2022 07:00 | C4XD | Proposed Placing to Raise Up To £5.7 million | RNS |
02.08.2022 18:01 | C4XD | IN BRIEF: C4X Discovery sees momentum across drug discovery portfolio | Alliance |
02.08.2022 07:00 | C4XD | Business Update | RNS |
01.08.2022 15:09 | C4XD | Block Listing Interim Review | RNS |
06.07.2022 19:33 | C4XD | IN BRIEF: C4X Discovery receives milestone payment from Sanofi deal | Alliance |
06.07.2022 07:00 | C4XD | C4X Discovery receives Sanofi milestone payment | RNS |
28.06.2022 17:46 | C4XD | AIM Rule 17 Schedule 2(g) Update | RNS |
28.04.2022 19:25 | ASPL, CREO, IQAI | TRADING UPDATES: Impellam's first quarter beats pre-virus levels | Alliance |
28.04.2022 07:00 | C4XD | Half Year Results | RNS |
21.04.2022 16:10 | WTB, ULVR, STJ | UK earnings, trading statements calendar - next 7 days | Alliance |
19.04.2022 07:00 | C4XD | Notice of Results | RNS |
28.02.2022 17:30 | C4XD | Exercise of Options, Issue of Equity and TVR | RNS |